Skip to main content
. 2020 Oct 28;2020:1509501. doi: 10.1155/2020/1509501

Table 3.

Prevalence of thalassemia in GCC countries.

Country Study ID Children below five years Children above five years Adults Event Total Percent
Patients with thalassemia
Saudi Arabia AlHamdan et al. (2007) [41] No No Yes 348 488315 0.07%
Alsaeed et al. (2011) [39] No No Yes 33 329 10.0%
Alsaeed et al. (2018) [42] No Yes Yes 787 1230582 0.064%
El-Hazmi et al. (1982) [44] Yes Yes Yes Not mentioned 2643 30.72%
Memish et al. (2011) [45] No No Yes 29 006 1572140 1.8%
Nasserullah et al. (2003) [46] Yes No No 7923 21858 36%
Ganeshaguru et al. (1987) [32] No No Yes 840
 (i) β-thalassemia 25 840 3.0%
 (ii) α/β-thalassemia 8 0.9%
 (iii) α-thalassemia 364 43.3%
UAE Barakat-Haddad et al. (2013) [36] No Yes No 57 6329 0.9%
Denic et al. (2013) [37] No No Yes 2 5672 0.035%
El-kalla et al. (1998) [38] Yes No No 46 418 11%
Kingdom of Bahrain Al-arrayed et al. (2003) [34] No Yes Yes 5 5685 0.09%
Kuwait Adekile et al. (1996) [35] Yes Yes No 12 39 30.7%
Patients with β-thalassemia and sickle cell disease
Saudi Arabia Alsaeed et al. (2011) [39] Yes Yes Yes 11 329 3.3%
Pembrey et al. (1980) [30] Yes Yes No 16 140 11.43%
Perrine et al. (1981) [31] Yes No No 6 2341 0.25%
Bahrain Rajab et al. (2006) [33] No No Yes 34 282 12%
Qatar Fawzi et al. (2003) [47] No No Yes Not mentioned 3275 1.37%